Paydirt
Insider filing · KNSA

Barry D Quart sold $836K of Kiniksa Pharmaceuticals International (KNSA)

Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.

Value, as filed
$836K
20,129 sh × $41.51
Executed
Dec 15 2025
the trade date, as filed
Disclosed
Dec 17 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
BQ Barry D Quart Director profile →

Barry D Quart (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $836K of KNSA (20,129 sh × $41.51, as filed), executed Dec 15 2025.

The name
KNSA Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Barry D Quart in KNSA
KNSASALE Kiniksa Pharmaceuticals International, plc $656K
13,099 sh × $50.10
Exec Apr 28
Filed Apr 29 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $345K
6,901 sh × $50.00
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $121K
2,690 sh × $45.00
Exec Feb 12
Filed Feb 12 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $684K
15,130 sh across 2 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $833K
27,448 sh across 3 lots
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET